SOPH·H82027105·US·equity·Healthcare - Health Information Services-13D/G
ORDINARY SHARES
SOPH (SOPHIA GENETICS SA) is held by 30 institutional investors as of Q1 2026. Largest holders: GENERATION INVESTMENT MANAGEMENT LLP ($33.6M), AKRE CAPITAL MANAGEMENT LLC ($18.4M), BANQUE PICTET & CIE SA ($10.9M). Net institutional sentiment: Mixed.
See how SOPH's score breaks down across 4 SEC sources
Showing 1-20 of 36
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer